Wei‐Zen Wei

2.5k total citations
69 papers, 1.9k citations indexed

About

Wei‐Zen Wei is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wei‐Zen Wei has authored 69 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Immunology, 34 papers in Oncology and 23 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wei‐Zen Wei's work include Immunotherapy and Immune Responses (41 papers), Monoclonal and Polyclonal Antibodies Research (22 papers) and T-cell and B-cell Immunology (20 papers). Wei‐Zen Wei is often cited by papers focused on Immunotherapy and Immune Responses (41 papers), Monoclonal and Polyclonal Antibodies Research (22 papers) and T-cell and B-cell Immunology (20 papers). Wei‐Zen Wei collaborates with scholars based in United States, Italy and Sweden. Wei‐Zen Wei's co-authors include Marie P. Piechocki, Shari A. Pilon, Yi-chi M. Kong, Jennifer B. Jacob, Anne Galy, Guido Ferlazzo, Gerald P. Morris, Joyce Reyes, Ye-Shih Ho and Richard F. Jones and has published in prestigious journals such as Nature Immunology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Wei‐Zen Wei

69 papers receiving 1.9k citations

Peers

Countries citing papers authored by Wei‐Zen Wei

Since Specialization

Citations

This map shows the geographic impact of Wei‐Zen Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Zen Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Zen Wei more than expected).

Fields of papers citing papers by Wei‐Zen Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Zen Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Zen Wei. The network helps show where Wei‐Zen Wei may publish in the future.

Co-authorship network of co-authors of Wei‐Zen Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Zen Wei. A scholar is included among the top collaborators of Wei‐Zen Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Zen Wei. Wei‐Zen Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IFNγ PET Imaging as a Predictive Tool for Monitoring Response to Tumor Immunotherapy 2018 ·Cancer Research ·Heather M. Gibson, (unknown), (unknown), Greg Dyson, (unknown), Claire E. McCarthy, Joyce Reyes, Wei‐Zen Wei, Nerissa T. Viola	73
2	Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity 2018 ·Nanoscale ·Myunggi An, (unknown), (unknown), Joyce Reyes, Guangzhao Mao, Wei‐Zen Wei, Haipeng Liu	81
3	Induction of HER2 Immunity in Outbred Domestic Cats by DNA Electrovaccination 2015 ·Cancer Immunology Research ·Heather M. Gibson, Jesse Veenstra, Richard Jones, Ulka N. Vaishampayan, (unknown), Gerold Bepler, Lawrence G. Lum, Joyce Reyes, Amy Weise, Wei‐Zen Wei	11
4	Cryotherapy with Concurrent CpG Oligonucleotide Treatment Controls Local Tumor Recurrence and Modulates HER2/neu Immunity 2014 ·Cancer Research ·Jesse Veenstra, Heather M. Gibson, Peter J. Littrup, Joyce Reyes, Michael L. Cher, Akira Takashima, Wei‐Zen Wei	20
5	Combining Human and Rat Sequences in Her-2 DNA Vaccines Blunts Immune Tolerance and Drives Antitumor Immunity 2010 ·Cancer Research ·Jennifer B. Jacob, Elena Quaglino, Olga Radkevich-Brown, Richard F. Jones, Marie P. Piechocki, Joyce Reyes, Amy Weise, Augusto Amici, Wei‐Zen Wei	35
6	Antibody-Dependent Natural Killer Cell–Mediated Cytotoxicity Engendered by a Kinase-Inactive Human HER2 Adenovirus-Based Vaccination Mediates Resistance to Breast Tumors 2010 ·Cancer Research ·(unknown), Simona Vertuani, Claudia Curcio, Agnese Antognoli, (unknown), Göran Akusjärvi, Wei‐Zen Wei, Federica Cavallo, Rolf Kiessling	23
7	Tumor Regression following DNA Vaccination and Regulatory T Cell Depletion in neu Transgenic Mice Leads to an Increased Risk for Autoimmunity 2009 ·The Journal of Immunology ·Jennifer B. Jacob, Yi-chi M. Kong, ILKe Nalbantoglu, Daniel P. Snower, Wei‐Zen Wei	35
8	Genetic Regulation of the Response to Her-2 DNA Vaccination in Human Her-2 Transgenic Mice 2008 ·Cancer Research ·Olga Radkevich-Brown, Jennifer B. Jacob, Michael H. Kershaw, Wei‐Zen Wei	26
9	Dendritic cells pulsed with an anti-idiotype antibody mimicking Her-2 induced protective antitumor immunity in mice transgenic for human Her-2 2008 ·Cancer Research ·Asim Saha, (unknown), Sunil K. Chatterjee, Kenneth A. Foon, Wei‐Zen Wei, (unknown)	1
10	DNA Vaccination Controls Her-2+ Tumors that Are Refractory to Targeted Therapies 2008 ·Cancer Research ·(unknown), Marie P. Piechocki, Henry H. Heng, Jennifer B. Jacob, Richard F. Jones, (unknown), Wei‐Zen Wei	24
11	The “A, B and C” of Her-2 DNA vaccine development 2008 ·Cancer Immunology Immunotherapy ·Wei‐Zen Wei, Jennifer B. Jacob, Olga Radkevich-Brown, (unknown), Yi-chi M. Kong	8
12	Control of Her-2 Tumor Immunity and Thyroid Autoimmunity by MHC and Regulatory T Cells 2007 ·Cancer Research ·Jennifer B. Jacob, Yi-chi M. Kong, (unknown), Daniel P. Snower, Chella S. David, Ye-Shih Ho, Wei‐Zen Wei	28
13	Prospects of Controlling Breast Cancer Metastasis by Immune Intervention 2007 ·Breast Disease ·Amy M. Fulton, Frederick W. Miller, Amy Weise, Wei‐Zen Wei	19
14	Concurrent Induction of Antitumor Immunity and Autoimmune Thyroiditis in CD4+CD25+ Regulatory T Cell–Depleted Mice 2005 ·Cancer Research ·Wei‐Zen Wei, Jennifer B. Jacob, John Zielinski, Jeffrey C. Flynn, (unknown), (unknown), Alvaro A. Giraldo, Yi-chi M. Kong	84
15	Broadening of Epitope Recognition During Immune Rejection of ErbB-2-Positive Tumor Prevents Growth of ErbB-2-Negative Tumor 2003 ·The Journal of Immunology ·Shari A. Pilon, (unknown), Wei‐Zen Wei	38
16	Quantitative measurement of anti-ErbB-2 antibody by flow cytometry and ELISA 2002 ·Journal of Immunological Methods ·Marie P. Piechocki, Shari A. Pilon, Wei‐Zen Wei	35
17	Vaccination with Cytoplasmic ErbB-2 DNA Protects Mice from Mammary Tumor Growth Without Anti-ErbB-2 Antibody 2001 ·The Journal of Immunology ·Shari A. Pilon, Marie P. Piechocki, Wei‐Zen Wei	61
18	Complementary Antitumor Immunity Induced by Plasmid DNA Encoding Secreted and Cytoplasmic Human ErbB-2 2001 ·The Journal of Immunology ·Marie P. Piechocki, Shari A. Pilon, Wei‐Zen Wei	62
19	Adoptive transfer of V beta 2-deleting activity with host cells from mice implanted with C4 preneoplastic hyperplastic alveolar nodules. 1992 ·PubMed ·Wei‐Zen Wei, Hong Wang, (unknown), Robert J. Pauley	7
20	Characterization of lymphocytic infiltrates in normal, preneoplastic, and neoplastic mouse mammary tissues. 1986 ·PubMed ·Wei‐Zen Wei, Kevin J. Malone, (unknown), Gloria H. Heppner	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact